Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.01 USD
Change Today -0.0015 / -13.04%
Volume 104.0K
RGDXQ On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

response genetics inc (RGDXQ) Snapshot

Open
$0.01
Previous Close
$0.01
Day High
$0.01
Day Low
$0.0063
52 Week High
09/4/14 - $0.82
52 Week Low
08/24/15 - $0.0051
Market Cap
388.0K
Average Volume 10 Days
128.3K
EPS TTM
$-0.36
Shares Outstanding
38.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RESPONSE GENETICS INC (RGDXQ)

Related News

No related news articles were found.

response genetics inc (RGDXQ) Related Businessweek News

No Related Businessweek News Found

response genetics inc (RGDXQ) Details

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California. On August 9, 2015, Response Genetics, Inc filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

96 Employees
Last Reported Date: 03/31/15
Founded in 1999

response genetics inc (RGDXQ) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $767.9K
Chief Financial Officer
Total Annual Compensation: $327.6K
Compensation as of Fiscal Year 2014.

response genetics inc (RGDXQ) Key Developments

Response Genetics Receives Delisting Notice From NASDAQ

On August 23, 2015, Response Genetics, Inc. received notice from The NASDAQ Stock Market that it will delist the common stock of the company. The company’s stock was suspended on July 06, 2015 and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed.

Response Genetics, Inc will Change its Ticker to RGDX.Q from RGDX

Effective August 11, 2015, Response Genetics, Inc will change its Pink Sheets LLC stock ticker symbol to RGDX.Q from RGDX.

Response Genetics, Inc(OTCPK:RGDX) dropped from NASDAQ Composite Index

Response Genetics, Inc will be removed from Nasdaq Composite Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGDXQ:US $0.01 USD -0.0015

RGDXQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RGDXQ.
View Industry Companies
 

Industry Analysis

RGDXQ

Industry Average

Valuation RGDXQ Industry Range
No financial data is available for RGDXQ.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE GENETICS INC, please visit www.responsegenetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.